CD19 and acute lymphoblastic leukemia: Moreover, PB‐derived CD19 CAR NK cells infusion combined with anti‐CD20 mAb treatment increased the release of effector cytokines and tumor cell clearance in mice xenografted with B‐ALL cells while retaining the expression and function of native activating receptors.182